Inari Medical to Present at Upcoming Investor Conferences

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI), a medical device company specializing in treatments for venous diseases, announced its participation in two upcoming investor conferences. The first is the BTIG MedTech Conference on February 15, 2022, at 12:00 p.m. Eastern Time. The second is the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 1:00 p.m. Eastern Time, with a live audio webcast available. Inari develops innovative catheter-based devices for the non-surgical treatment of conditions like deep vein thrombosis and pulmonary embolism.

IRVINE, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the following investor conferences:

• BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
  Presenting on Tuesday, February 15, 2022 at 12:00 p.m. Eastern Time.
  The webcast link is available only for those who are attending the BTIG conference.

• 11^th Annual SVB Leerink Global Healthcare Conference
  Presenting on Friday, February 18, 2022 at 1:00 p.m. Eastern Time.
  A live audio webcast and replay of the SVB Leerink presentation may be accessed on the “Investor
  Relations” section of the company’s website at: https://www.inarimedical.com/.

About Inari Medical, Inc.

Inari Medical, Inc. is a medical device company focused on developing innovative products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by FDA and CE marked for the non-surgical removal of clot from peripheral blood vessels, including for the use in the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by FDA and CE marked for the non-surgical removal of clot from peripheral blood vessels, including for the use in the treatment of pulmonary embolism and clot in transit in the right atrium.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

When will Inari Medical present at the BTIG MedTech Conference?

Inari Medical will present at the BTIG MedTech Conference on February 15, 2022, at 12:00 p.m. Eastern Time.

What date is the SVB Leerink Global Healthcare Conference where Inari Medical will present?

Inari Medical will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 1:00 p.m. Eastern Time.

How can I access the webcast for Inari Medical's SVB Leerink presentation?

The webcast for Inari Medical's SVB Leerink presentation can be accessed on the 'Investor Relations' section of their website.

What is the main focus of Inari Medical's products?

Inari Medical focuses on developing innovative devices specifically designed for treating venous diseases, particularly deep vein thrombosis and pulmonary embolism.

What products has Inari Medical developed for venous diseases?

Inari Medical has developed catheter-based mechanical thrombectomy devices, including the ClotTriever and FlowTriever systems, for treating venous thromboembolism.